NIAID | Technology Transfer

EPSTEIN-BARR VIRUS VACCINES

Read more about EPSTEIN-BARR VIRUS VACCINES

US Patent 12,005,115
Filed on 2020-07-07

TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS

Read more about TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS

US Application 16/968,792
Filed on 2020-08-10

TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS

Read more about TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS

European Patent
19709243.0
Filed on 2019-02-19

VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

US Patent 11,390,651
Filed on 2020-08-31

Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

US Patent 11,753,627
Filed on 2020-09-01

USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS

Read more about USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS

Hong Kong
19127785.4
Filed on 2017-04-18

BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

US Patent 11,369,675
Filed on 2020-07-21

Development Of A Broadly Protective Influenza Vaccine Consisting Of A Cocktail Of Inactivated Avian Influenza Viruses 1

Read more about Development Of A Broadly Protective Influenza Vaccine Consisting Of A Cocktail Of Inactivated Avian Influenza Viruses 1

India
202017031357
Filed on 2019-01-18

BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

European Patent
19717381.8
Filed on 2019-01-18

BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

China
201980009484.7
Filed on 2019-01-18

Subscribe to NIAID